Fig. 2From: Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81–8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare settingFVIII concentrations over time95CI: 95% confidence interval; rAHF-PFM: antihemophilic factor (recombinant) plasma/albumin-free method; BAY: BAY 81–8973Back to article page